Skip to main content

Table 3 Patients’ intraoperative and postoperative parameters

From: Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer

  In situ (n = 68) Ex situ (n = 118) Splenectomy (n = 31) Pvalue
No. of harvested SHLNs, median (range) 1(1–4) 2(1–7) 2(1–7) 0.047
No. of total harvested LNs, median (range) 33(10–66) 33(11–78) 31(11–60) 0.313
Postoperative hospital stay, days, (mean ± standard deviation) 16.41 ± 3.06 15.11 ± 1.53 23.26 ± 4.74 0.001
Blood loss volume, ml, (mean ± standard deviation) 211.62 ± 53.43 180.08 ± 24.71 262.90 ± 78.09 0.027
Operation duration, min, (mean ± standard deviation) 242.66 ± 18.90 244.24 ± 13.66 247.65 ± 22.06 0.695
Postoperative complication rate, n (%) 12(17.6 %) 15(12.7 %) 11(35.5 %) 0.011
Bleeding, n (%) 1 (1.5 %) 3 (2.5 %) 3 (9.7 %) 0.153
Anastomotic leak, n (%) 3 (4.4 %) 6 (5.1 %) 5 (16.1 %) 0.111
Pancreatic fistula, n (%) 0 (0.0 %) 0 (0.0 %) 2 (6.5 %) 0.019
Abdominal effusion, n (%) 6 (8.8 %) 7 (5.9 %) 5 (16.1 %) 0.183
Abdominal infection, n (%) 6 (8.8 %) 8 (6.8 %) 7(22.6 %) 0.029
Pneumonia, n (%) 3 (8.8 %) 1 (0.8 %) 1(3.2 %) 0.269
Reoperation rate, n (%) 3(4.4 %) 3(2.5 %) 2(6.5 %) 0.359
Mortality rate, n (%) 0(0 %) 1(0.8 %) 1(3.2 %) 0.363
  1. SHLNs splenic hilar lymph nodes, LNs lymph nodes